IBM
50
-7
AVGO
54
14
CRM
47
8
FLS
63
7
A
43
2
INTC
29
5
MPC
42
-2
MTCH
50
4
PM
74
4
TXN
48
10
ADT
58
-6
OI
47
5
TGT
47
4
EXPD
29
5
MCHP
54
7
ORCL
56
7
USB
53
2
LEN
19
2
PVH
52
13
EOG
46
3
IBM
50
-7
AVGO
54
14
CRM
47
8
FLS
63
7
A
43
2
INTC
29
5
MPC
42
-2
MTCH
50
4
PM
74
4
TXN
48
10
ADT
58
-6
OI
47
5
TGT
47
4
EXPD
29
5
MCHP
54
7
ORCL
56
7
USB
53
2
LEN
19
2
PVH
52
13
EOG
46
3
Financhill
Back

NeuroPace Stock Predictions

This tech company grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

NPCE
NeuroPace

Last Price:
$11.13
Seasonality Move:
-29.24%

7 Day Trial

ALL ACCESS PASS

$ 7

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

NeuroPace Stock Forecast

  • Over the next 52 weeks, NeuroPace has on average historically risen by 37.8% based on the past 4 years of stock performance.
  • NeuroPace has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is NeuroPace Stock Undervalued?
    The current NeuroPace [NPCE] share price is $11.25. The Score for NPCE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NPCE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will NeuroPace Stock Go Up Next Year?

  • Over the next 52 weeks, NeuroPace has on average historically risen by 37.8% based on the past 4 years of stock performance.

NeuroPace Stock Rating

Sell
27
NeuroPace (NPCE) is a Sell

Is NeuroPace overpriced?

  • NeuroPace has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

NeuroPace Stock Price History

Is NPCE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NPCE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
neuropace.com

52-Week Data

52-Week High:
15.11
52-Week Low:
5.45

Prediction Charts

Market Cap:
366.3M
Price in USD:
11.25
Volume:
101.8K
Beta:
2.04

Technical Analysis

SMA50:
11.89
SMA100:
11.98
SMA200:
9.62
52-Wk Change:
-17.04%

Stock Predictions

  • Is NeuroPace stock public?
    Yes, NeuroPace is a publicly traded company.
  • What is the NeuroPace stock quote today?
    The NeuroPace stock price is 11.25 USD today.
  • How to buy NeuroPace stock online?
    You can buy NeuroPace shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-7 11.44 12.30 12.67 11.03
Apr-8 12.55 11.10 12.55 10.84
Apr-9 10.88 11.67 12.01 10.18
Apr-10 11.19 10.64 11.56 10.43
Apr-11 10.54 10.42 10.75 9.89
Apr-14 10.74 10.67 10.95 10.44
Apr-15 10.72 10.34 11.51 10.26
Apr-16 10.15 10.43 10.57 10.15
Apr-17 10.42 10.79 10.95 10.25
Apr-21 10.66 10.54 10.66 10.02
Apr-22 10.71 10.94 11.00 10.42
Apr-23 11.35 10.91 11.76 10.75
Apr-24 10.92 11.25 11.36 10.92
Apr-25 11.10 11.15 11.29 10.89

NeuroPace Earnings

NeuroPace Earnings Report: Per Share NeuroPace Earnings Q1 Q2 Q3 and Q4 last year and next year.

NeuroPace Forecast Revenue Growth

NeuroPace Stock Analysis: Historical quarterly revenues per share for NeuroPace and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.15 per share, and an increase next year of $0.30 per share.

* NeuroPace stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.